The complexity of software architecture and diverse user interactions presents challenges to conventional testing approaches. Traditional test automation and quality assurance engineering represented ...

In a precarious world of rapidly growing pandemics, the field of vaccine production has witnessed considerable growth. Bacillus Calmette-Guérin (BCG) is a live-attenuated vaccine and a part of the ...

Tools for rapid identification of novel and/or emerging viruses are urgently needed for clinical diagnosis of unexplained infections and pandemic preparedness. Here we developed and clinically ...

The US Food and Drug Administration (FDA) on Wednesday finalized guidance to help industry develop and validate immune assays for the assessment of the immunogenicity of therapeutic protein products ...

Acquired CARD11 Mutation Promotes BCR Independence in Diffuse Large B Cell Lymphoma Despite the well-understood benefits of biomarker and genetic testing in precision medicine, uptake remains low, ...

Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer generates results in as little as 24 hours to support timely therapy decisions A patient’s tumor profile has the potential ...

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that the validation study of ...

The Single-antigen Bead (SAB) assay has revolutionized the detection of anti-HLA antibodies, which are critical in transplantation medicine. Despite its advantages, several limitations and challenges ...

For people with stable chest pain, a personalized "precision" testing approach led to more efficient evaluations for heart disease risk and improved diagnosis and treatment of coronary artery disease ...

Next-generation sequencing (NGS) has become increasingly popular with testing laboratories allowing them to obtain more data in less time and with minimal input. In this webinar we will explore the ...

Immuno Oncology Assay Market Driven by Rising Cancer Prevalence, Expanding Clinical Applications, Checkpoint Inhibitor Adoption, and Reimbursement Expansion to Register 11.8% CAGR Growth Through 2036 ...